What is Homage?
Homage operates as an award-winning healthcare solution provider, bridging the gap between professional medical services and the growing demand for home-based care. The platform utilizes a sophisticated blend of curated care professionals, including nurses and therapists, alongside smart technology to manage complex health needs. Its service portfolio spans from Activities of Daily Living (ADL) assistance to specialized rehabilitation for chronic conditions such as stroke, dementia, and Parkinson's disease.
By collaborating with government bodies and financial institutions, Homage has established itself as a critical infrastructure component in the regional care economy. The company's market position is defined by its commitment to enabling seniors and adults to recover with dignity, effectively decentralizing healthcare delivery from traditional clinical settings to the home environment.
How much funding has Homage raised?
Homage has raised a total of $45.4M across 4 funding rounds:
Angel/Seed
$1.2M
Series A
$4.2M
Series B
$10M
Series C
$30M
Angel/Seed (2017): $1.2M with participation from SeedPlus, Golden Gate Ventures, and 500 Startups Incubator, LLC
Series A (2018): $4.2M, investors not publicly disclosed
Series B (2020): $10M supported by Alternate Ventures, EV Growth, HealthXCapital, and KDV Capital
Series C (2021): $30M featuring Sheares Healthcare Group, East Ventures, HealthXCapital, DG Daiwa Ventures, and Sagana
Key Investors in Homage
Sheares Healthcare Group
A subsidiary of Temasek, this group specializes in healthcare delivery services across Asia, focusing on the design and operation of advanced medical facilities.
East Ventures
A prominent Southeast Asian venture capital firm known for supporting visionary founders from Seed to Growth stages with a focus on sustainable development.
HealthXCapital
An early-stage venture capital platform dedicated to innovative healthcare startups in emerging markets, providing operational support to enhance care accessibility.
What's next for Homage?
With the successful closure of its latest funding round, Homage is entering a critical phase of enterprise-level scaling. The strategic focus will likely shift toward enhancing its proprietary technology stack to improve care matching algorithms and expanding its footprint in emerging markets. Given the involvement of institutional investors with deep healthcare expertise, the company is expected to prioritize the integration of advanced medical data analytics to further personalize patient outcomes.
Furthermore, the firm is poised to strengthen its partnerships with regional health systems, potentially diversifying its revenue streams through B2B collaborations. As the demand for community-based care continues to rise, Homage's ability to maintain high service standards while scaling its workforce will be the primary determinant of its long-term market leadership.
